Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$302,103
+$8,596 QoQ
Shares Held
2,351
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#3,161
of 3,769 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. MRK ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 |
All Filings in MRK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,103 | 2,351 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $293,507 | 2,440 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,669,844 | 15,864 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,149,841 | 13,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $861,102 | 10,878 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $976,409 | 10,878 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $995,993 | 10,012 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $835,574 | 7,358 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $692,661 | 5,595 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||